Fierce Healthcare5h
FDA declares semaglutide shortage over, spelling end to compounded GLP-1 market
The Food and Drug Administration on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and ...
The Ozempic Shortage Is Over
The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive ...
ScienceAlert on MSN22h
Ozempic Literally Came From a Monster – And It's Not Alone
The toxic bite of a Gila monster can kill a human, but a specific ingredient in the cocktail of the lizard's venom is the ...
Novo Nordisk’s OZEMPIC Approval Heat Up the Chronic Kidney Disease Therapeutic Market | DelveInsight
The FDA’s recent approval of OZEMPIC highlights the expanding use of GLP-1 drugs beyond diabetes and weight management. Novo Nordisk’s blockbuster medication has gained another label expansion, now ...
Semaglutide Side Effects: Is It Safe? What You Need To Know
Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...
Healthy Returns: Ozempic helps curb alcohol use in new study — and doctors are concerned about telehealth GLP-1s
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news ...
Crain's Chicago Business2d
Illinois AG urges FDA crackdown on 'counterfeit' GLP-1s
Kwame Raoul is among several state AGs raising the alarm following complaints about online teleheath company Hims & Hers ...
Hosted on MSN3d
Osteoporosis Biosimilar OK'd; New Endo Guidelines; A Hot Spot for Stealing Ozempic
The FDA approved the denosumab biosimilar Ospomyv, interchangeable with Prolia, for preventing osteoporosis-related fracture ...